The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers.
Manuel Rubio-RivasJosé M Mora-LujánAbelardo MonteroJosefa Andrea Aguilar GarcíaManuel Méndez BailónAna Fernández CruzIsabel OriolFrancisco-Javier Teigell-MuñozBeatriz Dendariena BorqueAndrés De la Peña FernándezRaquel Fernández GonzálezRicardo Gil SánchezJavier Fernández FernándezMarta CatalánBegoña Cortés-RodríguezCarmen Mella PérezLorena Montero RivasRebeca Suárez FuentetajaJara Eloísa Ternero VegaJavier EnaAnabel Martin-Urda Díez-CansecoCristina Pérez GarcíaJosé F VaronaJosé Manuel Casas-RojoJesús Millán Núñez-Cortésnull nullPublished in: Journal of general internal medicine (2021)
The prescription of CS alone or in combination with TCZ should be based on the degrees of inflammation and reserve the CS plus TCZ combination for patients at high and especially very high risk.